Alector Inc reports results for the quarter ended June 30 - Earnings Summary

• Alector Inc ALEC.OQ reported a quarterly adjusted loss of 30 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -40 cents. The mean expectation of six analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -54 cents to -35 cents per share.

• Revenue fell 47.8% to $7.87 million from a year ago; analysts expected $2.75 million.

• Alector Inc's reported EPS for the quarter was a loss of 30 cents​.

• The company reported a quarterly loss of $30.52 million.

• Alector Inc shares had risen by 2.1% this quarter and lost 24.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Alector Inc is $3.75, about 61.1% above its last closing price of $1.46

This summary was machine generated from LSEG data August 8 at 03:54 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)